Parathyroidectomy and the Risk of Major Cerebrovascular and Cardiovascular Events in the Elderly.

Autor: Grant RRC; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD., Moroz BE; Computing and Software Solutions for Science, LLC, Bethany Beach, DE., Nilubol C; Division of Nephrology and Hypertension, Department of Medicine, Medstar Georgetown University Medical Center, Washington, DC., Cahoon EK; Division of Cancer Epidemiology and Genetics, Biostatistics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Pfeiffer RM; Division of Cancer Epidemiology and Genetics, Biostatistics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nilubol N; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Publikováno v: Annals of surgery [Ann Surg] 2023 Dec 01; Vol. 278 (6), pp. 1032-1037. Date of Electronic Publication: 2023 Jul 17.

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.

Autor: Laha D; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Grant RRC; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Mishra P; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Boufraqech M; Department of Molecular Biosciences, College of Natural Sciences, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA., Shen M; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Zhang YQ; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Hall MD; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Quezado M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., De Melo MS; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Del Rivero J; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zeiger M; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Nilubol N; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. naris.nilubol@nih.gov.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Sep 23; Vol. 41 (1), pp. 282. Date of Electronic Publication: 2022 Sep 23.

Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.

Autor: Green BL; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Grant RRC; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Richie CT; Genetic Engineering and Viral Vector Core, Intramural Research Program, Biomedical Research Center, National Institute on Drug Abuse, Baltimore, Maryland, USA., Chatterjee B; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Sampaio De Melo M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Barr FG; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Agarwal SK; Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland, USA., Nilubol N; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2022 Jul 01; Vol. 187 (1), pp. 185-196.